BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27345788)

  • 21. Genetically engineered MAPT 10+16 mutation causes pathophysiological excitability of human iPSC-derived neurons related to 4R tau-induced dementia.
    Kopach O; Esteras N; Wray S; Abramov AY; Rusakov DA
    Cell Death Dis; 2021 Jul; 12(8):716. PubMed ID: 34274950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia patient carrying a homozygous Y275X mutation in CYP7B1 (SPG5).
    Hauser S; Höflinger P; Theurer Y; Rattay TW; Schöls L
    Stem Cell Res; 2016 Sep; 17(2):437-440. PubMed ID: 27879220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia patient carrying a homozygous R486C mutation in CYP7B1 (SPG5).
    Höflinger P; Theurer Y; Schüle R; Schöls L; Hauser S
    Stem Cell Res; 2016 Sep; 17(2):422-425. PubMed ID: 27879216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of induced pluripotent stem cell line (ZZUi007-A) from a 52-year-old patient with a novel CHCHD2 gene mutation in Parkinson's disease.
    Wang Y; Wang Z; Sun H; Mao C; Yang J; Liu Y; Liu H; Zhang S; Zhang J; Xu Y; Shi C
    Stem Cell Res; 2018 Oct; 32():87-90. PubMed ID: 30237140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frontotemporal Dementia Caused by the P301L Mutation in the MAPT Gene: Clinicopathological Features of 13 Cases from the Same Geographical Origin in Barcelona, Spain.
    Borrego-Écija S; Morgado J; Palencia-Madrid L; Grau-Rivera O; Reñé R; Hernández I; Almenar C; Balasa M; Antonell A; Molinuevo JL; Lladó A; Martínez de Pancorbo M; Gelpi E; Sánchez-Valle R
    Dement Geriatr Cogn Disord; 2017; 44(3-4):213-221. PubMed ID: 28934750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Closing the tau loop: the missing tau mutation.
    McCarthy A; Lonergan R; Olszewska DA; O'Dowd S; Cummins G; Magennis B; Fallon EM; Pender N; Huey ED; Cosentino S; O'Rourke K; Kelly BD; O'Connell M; Delon I; Farrell M; Spillantini MG; Rowland LP; Fahn S; Craig P; Hutton M; Lynch T
    Brain; 2015 Oct; 138(Pt 10):3100-9. PubMed ID: 26297556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frontotemporal dementia with parkinsonism linked to chromosome 17 with the MAPT R406W mutation presenting with a broad distribution of abundant senile plaques.
    Ishida C; Kobayashi K; Kitamura T; Ujike H; Iwasa K; Yamada M
    Neuropathology; 2015 Feb; 35(1):75-82. PubMed ID: 25377499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MAPT V363I variation in a sporadic case of frontotemporal dementia: variable penetrant mutation or rare polymorphism?
    Anfossi M; Bernardi L; Gallo M; Geracitano S; Colao R; Puccio G; Curcio SA; Frangipane F; Mirabelli M; Tomaino C; Smirne N; Maletta R; Bruni AC
    Alzheimer Dis Assoc Disord; 2011; 25(1):96-9. PubMed ID: 21343707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defective proteostasis in induced pluripotent stem cell models of frontotemporal lobar degeneration.
    Mahali S; Martinez R; King M; Verbeck A; Harari O; Benitez BA; Horie K; Sato C; Temple S; Karch CM
    Transl Psychiatry; 2022 Dec; 12(1):508. PubMed ID: 36494352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line SCA3.A11.
    Hansen SK; Borland H; Hasholt LF; Tümer Z; Nielsen JE; Rasmussen MA; Nielsen TT; Stummann TC; Fog K; Hyttel P
    Stem Cell Res; 2016 May; 16(3):553-6. PubMed ID: 27346190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiation of primordial germ cells from induced pluripotent stem cells of primary ovarian insufficiency.
    Leng L; Tan Y; Gong F; Hu L; Ouyang Q; Zhao Y; Lu G; Lin G
    Hum Reprod; 2015 Mar; 30(3):737-48. PubMed ID: 25586786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Juvenile frontotemporal dementia with parkinsonism associated with tau mutation G389R.
    Chaunu MP; Deramecourt V; Buée-Scherrer V; Le Ber I; Brice A; Ehrle N; El Hachimi K; Pluot M; Maurage CA; Bakchine S; Buée L
    J Alzheimers Dis; 2013; 37(4):769-76. PubMed ID: 23948919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human iPSC-Derived Neuronal Model of Tau-A152T Frontotemporal Dementia Reveals Tau-Mediated Mechanisms of Neuronal Vulnerability.
    Silva MC; Cheng C; Mair W; Almeida S; Fong H; Biswas MHU; Zhang Z; Huang Y; Temple S; Coppola G; Geschwind DH; Karydas A; Miller BL; Kosik KS; Gao FB; Steen JA; Haggarty SJ
    Stem Cell Reports; 2016 Sep; 7(3):325-340. PubMed ID: 27594585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Invited review: Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging.
    Ghetti B; Oblak AL; Boeve BF; Johnson KA; Dickerson BC; Goedert M
    Neuropathol Appl Neurobiol; 2015 Feb; 41(1):24-46. PubMed ID: 25556536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapidly Progressive Frontotemporal Dementia Associated with MAPT Mutation G389R.
    Sun L; Chen K; Li X; Xiao S
    J Alzheimers Dis; 2017; 55(2):777-785. PubMed ID: 27802239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maturation and phenotype of pathophysiological neuronal excitability of human cells in tau-related dementia.
    Kopach O; Esteras N; Wray S; Rusakov DA; Abramov AY
    J Cell Sci; 2020 May; 133(10):. PubMed ID: 32299835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of novel induced pluripotent stem cell (iPSC) line from a 16-year-old sialidosis patient with NEU-1 gene mutation.
    Liu SP; Hsu YH; Huang CY; Ho MC; Cheng YC; Wen CH; Lu HE; Tsai CH; Shyu WC; Hsieh PCH
    Stem Cell Res; 2018 Apr; 28():39-43. PubMed ID: 29414417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A unique common ancestor introduced P301L mutation in MAPT gene in frontotemporal dementia patients from Barcelona (Baix Llobregat, Spain).
    Palencia-Madrid L; Sánchez-Valle R; Fernández de Retana I; Borrego S; Grau-Rivera O; Reñé R; Hernández I; Almenar C; Rossi G; Caroppo P; Redaelli V; Le Ber I; Camuzat A; Brice A; Antonell A; Balasa M; Gelpi E; Lladó A; de Pancorbo MM
    Neurobiol Aging; 2019 Dec; 84():236.e9-236.e15. PubMed ID: 31537395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of induced pluripotent stem cells (IRMBi001-A) from an Alzheimer's disease patient carrying a G217D mutation in the PSEN1 gene.
    Auboyer L; Monzo C; Wallon D; Rovelet-Lecrux A; Gabelle A; Gazagne I; Cacheux V; Lehmann S; Crozet C
    Stem Cell Res; 2019 Jan; 34():101381. PubMed ID: 30677723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integration-free erythroblast-derived human induced pluripotent stem cells (iPSCs) from an individual with Ataxia-Telangiectasia (A-T).
    Bhatt N; Ghosh R; Roy S; Gao Y; Armanios M; Cheng L; Franco S
    Stem Cell Res; 2016 Sep; 17(2):205-207. PubMed ID: 27879207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.